Medicare CED Could Support, Benefit From Surveillance Systems Like FDA’s Sentinel – McClellan
Executive Summary
At a May 16 Medicare Evidence Development and Coverage Advisory Committee meeting, former CMS and FDA Chief Mark McClellan advocated salvaging Medicare’s little-used coverage with evidence development policy for medical products.